Indefinite Delivery Contract SPE2DX15D5013
- Not listed
- The federal contract IDV award SPE2DX15D1042 is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,999,999.00 contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on April 10, 2015, with a performance period through December 31, 2025. Under this IDC, Amerisourcebergen Drug Corp serves as the prime vendor responsible for delivering a comprehensive range of pharmaceutical...
- The federal contract IDV award SPE2DX15D1206 is an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a ceiling value of $4,999,999.00, with a period of performance through December 31, 2025. Under this IDC, Amerisourcebergen Drug Corp serves as the prime contractor responsible for providing a comprehensive range of pharmaceutical products and medical...
- The federal contract IDV award SPE2DX16D2911 is an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The single-award IDC, valued at up to $4,999,999.99, was issued by the Defense Logistics Agency (DLA) Troop Support Medical and runs through December 31, 2025. Under this IDC, Amerisourcebergen Drug Corp provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- The federal contract IDV award SPE2DX15D5021 is an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The IDC, valued at up to $999,999,999.00, enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This...
- The federal contract IDV award SPE2DX15D2004 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $4,999,999.00, runs through December 31, 2025 and aims to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses a broad spectrum...
- The federal contract IDV award, SPE2DX15D1921, is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $4,999,999.00, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and runs through December 31, 2025. Under this IDC, Amerisourcebergen Drug Corp provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- The federal contract IDV award SPE2DX15D6043 is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $4,999,999.00, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and runs through December 31, 2025. Under this IDC, Amerisourcebergen Drug Corp serves as the primary vendor for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
- The federal contract IDV award SPE2DX16D9940 is an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a ceiling value of $4,999,999.99 with a period of performance through December 31, 2025. Under this single-award IDC, Amerisourcebergen Drug Corp serves as the prime contractor providing a comprehensive range of...
- The federal contract IDV award SPE2DX15D6042 is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $4,999,999.00, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and runs through December 31, 2025. Under this IDC, Amerisourcebergen Drug Corp provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- The federal contract IDV award SPE2DX16D2921 is an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a ceiling value of $4,999,999.99 with a period of performance through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
The federal contract IDV award SPE2DX15D5013 is an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical with a total ceiling value of $4,999,999.00 and a period of performance through December 31, 2025. Under this IDC, Amerisourcebergen Drug Corp serves as the prime contractor responsible for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This IDC serves as the primary vehicle for the DLA to efficiently procure essential healthcare items for military treatment facilities, veterans' healthcare programs, and other federal medical institutions. In addition, Amerisourcebergen Drug Corp holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 3/30/15 |